Financials
- Market Capitalization 2.09 B
- Employee 647
- Founded 2004
- CEO N/A
- Website www.admabiologics.com
- Headquarter Delaware, United States
- FIGI BBG002NCK5M5
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
30.4
Rapporto prezzo/fatturato
8.76
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1961 | URGN UroGen Pharma Ltd. - Ordinary Shares | 43.62 USD | -4.13% | -6.76% | +8.18% | +129.58% | 2.13 B USD | ||
| 1972 | VCEL Vericel Corporation - Common Stock | 40.95 USD | -0.56% | -4.05% | -16.26% | +12.65% | 2.10 B USD | ||
| 1994 | STOK Stoke Therapeutics, Inc. - Common Stock | 31.62 USD | -2.98% | -2.07% | +8.10% | +59.78% | 2.04 B USD | ||
| 1996 | ZBIO Zenas BioPharma, Inc. - Common Stock | 31.27 USD | -4.14% | -3.49% | -0.32% | +18.18% | 2.04 B USD |